Waseem Hajjar | Clinical Medicine | Innovative Research Award

Published on by Health Scientists

Innovative Research Award

Waseem Hajjar — King Saud University, Saudi Arabia

Researcher Profile
Researcher Waseem Hajjar
Affiliation King Saud University
Country Saudi Arabia
Scopus ID 35518559800
Documents 76
Citations 1,154
h-index 17
Subject Area Clinical Medicine
Event Health Scientists Awards
ORCID 0000-0001-7916-972X

Waseem Hajjar is a researcher affiliated with King Saud University, Saudi Arabia. The supplied academic profile identifies 76 documents, 1,154 citations, and an h-index of 17. His scholarly identity is additionally represented through persistent ORCID, Scopus, and Google Scholar profiles. The Innovative Research Award profile presented here summarizes the supplied bibliometric and institutional information in a neutral academic format.

Abstract

Waseem Hajjar is a clinical medicine researcher affiliated with King Saud University, Saudi Arabia, whose scholarly record includes 76 indexed documents, 1,154 citations, and an h-index of 17 according to the supplied profile data. His research portfolio reflects sustained engagement with clinical research and scholarly communication. The Innovative Research Award profile recognizes his documented research activity, publication record, citation impact, and professional presence across academic platforms. His ORCID, Scopus, and Google Scholar identifiers provide persistent links for verification and facilitate discovery of his scholarly contributions. This page summarizes the supplied academic information and presents it in a neutral format internationally.

Keywords

Clinical medicine; clinical research; medical research; healthcare research; evidence-based medicine; biomedical research; academic publishing; research collaboration; scholarly communication; research impact; citation analysis; Scopus; ORCID; Google Scholar; King Saud University; Saudi Arabia; innovative research; medical science; health sciences.

Introduction

Waseem Hajjar’s academic profile is presented within the context of clinical medicine and scholarly research. The supplied information identifies King Saud University as his institutional affiliation and Saudi Arabia as his country. Bibliometric indicators provide a concise description of indexed research activity, while persistent identifiers enable readers to distinguish and verify the researcher’s scholarly record across major academic platforms. Scopus provides author-level indexing and citation information, whereas ORCID supplies a persistent researcher identifier.

Research Profile

Waseem Hajjar is affiliated with King Saud University in Saudi Arabia and is identified in Scopus by author ID 35518559800. The supplied profile records 76 documents, 1,154 citations, and an h-index of 17. His identifiers across Scopus and ORCID support consistent attribution and scholarly profile discovery within academic databases internationally. These platforms provide complementary approaches to discovering publications, citations, author identifiers, and scholarly outputs. Bibliographic databases may differ in coverage and indexing practices, so individual records should be consulted when precise publication-level information is required. [1]

Research Contributions

Waseem Hajjar’s research contributions can be described through documented publication activity in clinical medicine and the associated citation record. Metrics indicate sustained scholarly output rather than one contribution. Interpretation of research themes should rely on individual publications, methodologies, findings, clinical contexts, and independently documented evidence from relevant literature and sources. Assessment of clinical research contributions generally requires consideration of study design, methodological rigor, reproducibility, clinical relevance, and the extent to which findings contribute to established knowledge.  [2]

Publications

Waseem Hajjar’s publication record contains 76 documents in the supplied Scopus profile. These publications provide evidence to evaluate research themes, methods, collaborations, and clinical relevance. Because publication titles and bibliographic details were not supplied here, this section avoids assigning topics and instead directs readers to the author record for verification. The supplied document count should be understood as a database-specific indicator rather than a complete inventory of every scholarly output.  [1]

Research Impact

Waseem Hajjar’s supplied citation indicators include 1,154 citations and an h-index of 17. These measures provide quantitative descriptions of scholarly visibility within the indexed record, while interpretation depends on field, publication age, database coverage, collaboration patterns, and citation practices. They should therefore be considered alongside publication-level evidence and contextual assessment. Citation indicators are commonly used to describe patterns of scholarly attention, but they have recognized limitations. [3]

Award Suitability

Waseem Hajjar’s profile contains identifiable academic credentials, indexed publications, citation indicators, and persistent researcher identifiers relevant to consideration for an Innovative Research Award. Award suitability should be determined from documented evidence, including originality, methodological quality, research contribution, reproducibility, and relevance of individual studies, rather than from bibliometric indicators alone. For a comprehensive award assessment, individual publications and supporting evidence should be reviewed alongside the supplied profile information. [4]

Conclusion

Waseem Hajjar’s supplied academic profile documents an affiliation with King Saud University, a Scopus author record containing 76 documents, 1,154 citations, and an h-index of 17, together with persistent ORCID and Google Scholar identifiers. These details provide a structured overview of scholarly activity. More detailed evaluation should be based on the underlying publications and independently verifiable research evidence.

References

  1. Elsevier. (n.d.). Scopus author details: Waseem Hajjar, Author ID 35518559800. Scopus.
    https://www.scopus.com/authid/detail.uri?authorId=35518559800
  2. ORCID. (n.d.). Waseem Hajjar — ORCID record.
    https://orcid.org/0000-0001-7916-972X
  3. Kaaki, S., Barnawi, A. B., Robaidi, H. A., Maghrabi, A. A., Almaymuni, A. D., Alzahim, A., Almahmoud, A., Alsalem, K. A., Alshehri, Y. M., Alsharari, H. S., & Hajjar, W. M. (2026). Perioperative outcomes and safety of uniportal robotic-assisted thoracic surgery (U-RATS) for anatomic lung resection: A systematic review and meta-analysis. https://link.springer.com/article/10.1007/s11701-026-03349-x
  4. Health Scientists Awards. (n.d.). Health Scientists Awards.
    https://healthscientists.org/
  5. Google Scholar. (n.d.). Waseem Hajjar — Google Scholar profile.
    https://scholar.google.com/citations?user=7s7wbfUAAAAJ&hl=en&oi=ao

Bernd Fink | Clinical Medicine | Innovative Research Award

Published on by Health Scientists

Innovative Research Award

Bernd Fink
Affiliation Orthopaedic Clinic Markgröningen
Country Germany
Scopus ID 22943409800
Documents 176
Citations 3,339
h-index 29
Subject Area Clinical Medicine
Event Health Scientists Awards
ORCID 0000-0002-7485-3941
Bernd Fink – Orthopaedic Clinic Markgröningen, Germany

Bernd Fink is a German orthopaedic surgeon and clinical researcher whose scholarly work primarily focuses on hip and knee arthroplasty, implant fixation, revision surgery, prosthetic joint infection, and long-term orthopedic outcomes. His scientific publications have contributed to improving evidence-based clinical practice through investigations into implant performance, surgical techniques, and patient-centered treatment strategies. His academic profile reflects sustained engagement with musculoskeletal research and international collaboration within clinical medicine.[1]

Abstract

Bernd Fink has established an internationally recognized academic profile through clinical investigations involving hip arthroplasty, knee replacement, implant fixation, revision procedures, prosthetic joint infection, biomaterials, and orthopedic outcomes. His publications emphasize evidence-based surgical decision-making, implant longevity, patient safety, and postoperative functional recovery. By integrating clinical observations with long-term follow-up studies, his research supports improvements in orthopedic practice and healthcare quality. His contributions continue influencing musculoskeletal surgery through scientifically validated findings that benefit clinicians, researchers, and patients while strengthening international orthopedic literature and advancing modern clinical medicine through collaborative multidisciplinary research worldwide.[2]

Keywords

Hip Arthroplasty, Knee Arthroplasty, Revision Arthroplasty, Prosthetic Joint Infection, Cementless Implant, Implant Fixation, Acetabular Cup, Femoral Stem, Orthopaedic Surgery, Clinical Outcomes, Total Hip Replacement, Joint Reconstruction.

Introduction

Bernd Fink investigates orthopedic surgery through clinically relevant research addressing joint replacement, revision strategies, implant fixation, infection prevention, and long-term patient outcomes. His scholarly publications integrate practical surgical experience with scientific evaluation, supporting evidence-based improvements in musculoskeletal healthcare while strengthening contemporary orthopedic knowledge through internationally recognized clinical investigations.[1]

Research Profile

Bernd Fink maintains an active research profile centered on hip arthroplasty, knee replacement surgery, prosthetic joint infection, implant survival, revision procedures, and orthopedic biomechanics. His publications demonstrate sustained collaboration with international researchers while contributing valuable clinical evidence supporting safer surgical interventions and improved patient rehabilitation across orthopedic practice.[2]

Research Contributions

Bernd Fink contributes significantly by evaluating implant performance, optimizing revision arthroplasty techniques, investigating prosthetic infections, and improving postoperative recovery through evidence-based orthopedic studies. His findings assist clinicians in selecting effective surgical approaches while promoting durable implant performance and enhanced quality of patient-centered musculoskeletal healthcare internationally.[3]

Publications

Bernd Fink has published extensively on hip arthroplasty, knee replacement, prosthetic joint infection, implant fixation, revision surgery, and long-term orthopedic outcomes. His scholarly articles emphasize evidence-based surgical practice, implant longevity, patient recovery, and clinical decision-making, providing valuable scientific knowledge that supports continuous advancements in modern orthopedic medicine worldwide.[3]

Research Impact

Bernd Fink’s research provides clinically meaningful evidence supporting orthopedic surgeons managing complex arthroplasty cases. His publications strengthen understanding of implant longevity, revision surgery, prosthetic infection prevention, and postoperative rehabilitation. These scholarly contributions continue supporting healthcare professionals seeking reliable evidence for improving orthopedic surgical quality and patient outcomes.[4]

Award Suitability

Bernd Fink demonstrates qualities consistent with recognition through the Innovative Research Award because his sustained orthopedic investigations have strengthened evidence-based clinical medicine. His scholarly contributions, publication record, international visibility, and commitment to improving arthroplasty outcomes collectively reflect meaningful scientific achievement deserving academic recognition within contemporary health sciences.[4]

Conclusion

Bernd Fink continues contributing valuable scientific knowledge through orthopedic clinical research emphasizing implant performance, revision surgery, infection management, and patient outcomes. His publications support evidence-based healthcare while promoting continuous improvements in musculoskeletal medicine. His academic achievements illustrate a sustained commitment to advancing clinical medicine through rigorous scientific investigation.[2]

References

  1. Scopus Author Profile. Bernd Fink.
    https://www.scopus.com/authid/detail.uri?authorId=22943409800
  2. ORCID. Bernd Fink Research Profile.
    https://orcid.org/0000-0002-7485-3941
  3. Fink, B., & Tetsworth, K. D. (2017). Antibiotic elution from cement spacers and its influencing factors.
    https://doi.org/10.3390/antibiotics14070705
  4. ResearchGate Profile.
    https://www.researchgate.net/profile/Bernd-Fink-3
  5. Health Scientists Awards.
    https://healthscientists.org/

Sarfaraz Niazi | Clinical Medicine | Lifetime Achievement Award

Published on by Health Scientists

Lifetime Achievement Award

Sarfaraz Niazi
Affiliation Washington State University
Country United States
Scopus ID 7004749563
Documents 156
Citations
2,572
h-index 26
Subject Area Clinical Medicine
Event Health Scientists Awards
ORCID 0000-0002-0513-0336

Sarfaraz Niazi
Washington State University, United States

Sarfaraz Niazi is an internationally recognized pharmaceutical scientist whose scholarly work has significantly influenced pharmaceutical formulation science, manufacturing technologies, dosage form development, drug delivery systems, regulatory sciences, and pharmaceutical product commercialization. His publications, technical handbooks, and scientific contributions have been extensively utilized by academic researchers, pharmaceutical industries, regulatory professionals, and healthcare innovators worldwide. His sustained research productivity, educational publications, and practical innovations demonstrate long-term contributions to clinical medicine and pharmaceutical sciences deserving scholarly recognition.[1]

Abstract

Sarfaraz Niazi has established a distinguished academic career through influential research, authoritative pharmaceutical reference books, and practical innovations supporting drug formulation, pharmaceutical manufacturing, analytical development, quality assurance, and commercialization. His scholarly publications have contributed to improving pharmaceutical education, industrial manufacturing practices, regulatory understanding, and formulation science across diverse healthcare applications. The breadth of his scientific output, sustained international citation record, and educational influence demonstrate enduring contributions to clinical medicine and pharmaceutical sciences while supporting innovation, professional training, and evidence-based pharmaceutical development worldwide.[2]

Keywords

Pharmaceutical formulation, Drug delivery, Pharmaceutical manufacturing, Dosage forms, Preformulation, Drug development, Regulatory science, Clinical medicine, Pharmaceutical technology, Quality assurance, Drug discovery, Formulation development.

Introduction

Sarfaraz Niazi has contributed extensively to pharmaceutical sciences through multidisciplinary research integrating formulation development, manufacturing technologies, analytical methodologies, and industrial pharmaceutical practice. His scientific publications and reference books continue supporting researchers, educators, pharmaceutical manufacturers, and healthcare professionals seeking evidence-based approaches for modern pharmaceutical product development and commercialization.[3]

Research Profile

Sarfaraz Niazi has maintained an internationally recognized scholarly profile characterized by influential publications, comprehensive pharmaceutical textbooks, industrial expertise, and sustained academic engagement. His research spans pharmaceutical manufacturing, formulation optimization, regulatory sciences, dosage form technologies, and translational pharmaceutical innovation supporting healthcare advancement through scientific excellence.[1]

Research Contributions

Sarfaraz Niazi has advanced pharmaceutical sciences by developing authoritative resources addressing formulation strategies, manufacturing processes, quality systems, and commercialization pathways. His publications bridge academic knowledge with industrial implementation, strengthening pharmaceutical education while facilitating innovation in drug development, product quality, and therapeutic manufacturing technologies worldwide.[4]

Publications

Sarfaraz Niazi has authored influential books and peer-reviewed publications covering pharmaceutical preformulation, liquid dosage manufacturing, computer-aided drug discovery, pharmaceutical technologies, and industrial formulation sciences. These scholarly resources remain widely referenced within universities, pharmaceutical industries, regulatory organizations, and professional research environments internationally.[5]

Research Impact

Sarfaraz Niazi has generated enduring academic and industrial influence through publications supporting pharmaceutical innovation, formulation optimization, manufacturing quality, and educational advancement. His scholarly contributions continue assisting researchers and healthcare industries in developing effective pharmaceutical products while strengthening evidence-based pharmaceutical sciences internationally.[2]

Award Suitability

Sarfaraz Niazi demonstrates sustained scholarly excellence through influential research publications, internationally recognized pharmaceutical references, educational leadership, and practical industrial innovation. These long-term scientific achievements, combined with substantial global academic influence, strongly align with the objectives and recognition standards associated with the Lifetime Achievement Award.[1]

Conclusion

Sarfaraz Niazi has built an internationally respected scientific legacy through pharmaceutical research, industrial innovation, educational scholarship, and authoritative publications. His lasting influence across pharmaceutical sciences, clinical medicine, formulation technology, and healthcare education reflects the sustained excellence expected from recipients of distinguished international scientific recognition.[5]

References

  1. Elsevier. (n.d.). Scopus author details: Sarfaraz Niazi, Author ID 7004749563. Scopus.
    https://www.scopus.com/pages/authors/7004749563
  2. ORCID. (n.d.). Sarfaraz Niazi ORCID Record.
    https://orcid.org/0000-0002-0513-0336
  3. Google Scholar. (n.d.). Scholar Profile: Sarfaraz Niazi.
    https://scholar.google.com/citations?user=O2dgTYIAAAAJ&hl=en&oi=ao
  4. ResearchGate. (n.d.). Sarfaraz Niazi Research Profile.
    https://www.researchgate.net/profile/Sarfaraz-Niazi-3
  5. Niazi, S. K., & Mariam, Z. (2024). Computer-aided Drug Design and Drug Discovery: A Prospective Analysis. Pharmaceuticals.
    https://doi.org/10.3390/ph17010022

Konstantin Konstantinov | Clinical Medicine | Innovative Research Award

Published on by Health Scientists

Innovative Research Award

Konstantin Konstantinov
Researcher Konstantin Konstantinov
Affiliation University of New Mexico
Country United States
Scopus ID 55808069944
Documents 38
Citations
2,384
h-index 17
Subject Area Clinical Medicine
Event Health Scientists Awards

Konstantin Konstantinov
University of New Mexico

Konstantin Konstantinov, affiliated with the University of New Mexico, is a researcher in Clinical Medicine whose scholarly work contributes to advancing evidence-based biomedical research. His publications indexed in Scopus demonstrate sustained engagement with clinically relevant investigations, interdisciplinary collaboration, and scientific dissemination. This recognition article summarizes his research profile, scholarly contributions, publication themes, research impact, and suitability for the Health Scientists Awards, based on publicly available academic records and recognized scholarly databases.[1]

Abstract

Konstantin Konstantinov has established an academic profile within Clinical Medicine through scholarly publications emphasizing translational biomedical research, disease mechanisms, diagnostic innovation, clinical applications, and collaborative investigation. His work reflects sustained participation in internationally indexed research while contributing to evidence-based healthcare knowledge. Publications demonstrate methodological rigor, scientific relevance, and interdisciplinary cooperation across medical sciences. Indexed visibility through Scopus and ORCID supports transparent scholarly communication and research accessibility. Collectively, these achievements indicate meaningful engagement with contemporary clinical research and provide a credible foundation for recognition through international academic awards dedicated to advancing health sciences and biomedical innovation.[1][2]

Keywords

Clinical Medicine, Biomedical Research, Translational Medicine, Disease Mechanisms, Biomarkers, Immunology, Molecular Medicine, Diagnostics, Therapeutics, Patient Care, Precision Medicine, Clinical Investigation, Medical Innovation, Healthcare Research, Evidence-Based Medicine.

Introduction

Konstantin Konstantinov conducts research emphasizing clinically relevant biomedical investigations that integrate laboratory findings with healthcare applications. His scholarly activities contribute to understanding disease processes, improving diagnostic strategies, and strengthening translational medicine. Indexed publications demonstrate consistent scientific engagement while supporting evidence-driven clinical practice across multidisciplinary healthcare environments.[1]

Research Profile

Konstantin Konstantinov maintains a recognized research profile through Scopus and ORCID, reflecting internationally indexed scholarly contributions. His affiliation with the University of New Mexico supports collaborative medical research, interdisciplinary partnerships, and dissemination of findings within respected scientific journals addressing clinical medicine and biomedical innovation.[2]

Research Contributions

Konstantin Konstantinov contributes to biomedical knowledge through investigations addressing clinical challenges, disease biology, and translational healthcare solutions. His research emphasizes scientific reliability, collaborative methodologies, and practical medical relevance, helping strengthen understanding of therapeutic development while supporting continued advancement of evidence-based clinical medicine internationally.[3]

Publications

Konstantin Konstantinov has authored and co-authored peer-reviewed publications indexed within Scopus, reflecting sustained participation in internationally recognized biomedical literature. His publication portfolio demonstrates scientific consistency, collaborative authorship, and continuing contributions to clinical medicine through research addressing contemporary healthcare questions and translational scientific applications.[1]

Research Impact

Konstantin Konstantinov demonstrates measurable scholarly visibility through internationally indexed publications, citation tracking, and persistent researcher identifiers. His scientific contributions encourage collaboration, knowledge dissemination, and continuing academic influence within clinical medicine while supporting reproducible research standards and responsible advancement of healthcare-related scientific investigation.[2]

Award Suitability

Konstantin Konstantinov demonstrates characteristics aligned with the objectives of the Health Scientists Awards through sustained scholarly productivity, internationally indexed research, interdisciplinary collaboration, and clinically relevant scientific contributions. His academic profile supports consideration for recognition based upon documented research quality, visibility, and professional scientific engagement.[4]

Conclusion

Konstantin Konstantinov represents an active clinical medicine researcher whose internationally indexed publications, institutional affiliation, and commitment to evidence-based biomedical investigation demonstrate meaningful scientific engagement. His documented academic profile provides an appropriate basis for professional recognition within international research award programs supporting healthcare innovation and scientific excellence.[1]

External Links

References

    1. Elsevier. (n.d.). Scopus Author Details: Konstantin Konstantinov, Author ID 55808069944. Scopus.
      https://www.scopus.com/authid/detail.uri?authorId=55808069944
    2. Konstantinov, K. N., Roldan, C. A., & Konstantinov, N. K. (n.d.). Sclerodactyly, tongue telangiectasias, premature severe aortic stenosis, and RNA polymerase III autoantibodies in a patient with syncope.
      https://pubmed.ncbi.nlm.nih.gov/37979901/

    3. Kumar, V., de Saint-Aubain, C. J., & Konstantinov, K. N. (n.d.). A diagnostic odyssey: Mevalonate kinase deficiency revealed by genetic testing in adulthood.

      https://doi.org/10.3390/genes17040439

    4. Health Scientists Awards. (n.d.). Official Awards Website.
      https://healthscientists.org/

Georg Feigl | Clinical Medicine | Research Excellence Award

Published on by Health Scientists

Prof. Dr. Georg Feigl | Clinical Medicine | Research Excellence Award

Institut für Anatomie und klinische Morphologie, Universität Witten | Germany

Prof. Dr. Georg Christoph Feigl is a Germany-based academic researcher at Universität Witten/Herdecke, specializing in clinical anatomy, surgical education, anesthesiology-related anatomy, and cadaver-based medical training. He has authored over 120 peer-reviewed publications, accumulating 2,419 citations with an h-index of 25, reflecting sustained international impact. His research focuses on anatomical optimization for surgical and interventional procedures, including regional anesthesia, orthopedic and thoracic surgery, and advanced cadaveric models (Thiel and Dodge embalming techniques). Prof. Feigl collaborates widely across disciplines, with 300+ co-authors, contributing to translational studies that bridge anatomy, imaging, and clinical practice. His work supports safer surgical techniques, improved medical training, and evidence-based procedural standards, delivering clear societal benefits through enhanced patient safety, education quality, and clinical outcomes.

Citation Metrics (Scopus)

2419
1800
1200
600
0

Citations

2,419

Documents

120

h-index

25

Citations

Documents

h-index

View Scopus Profile
 View ORCID Profile

Featured Publications

Eirini Kostopoulou | Clinical Medicine | Research Excellence Award

Published on by Health Scientists

Assist. Prof. Dr. Eirini Kostopoulou | Clinical Medicine | Research Excellence Award

Assistant Professor | University General Hospital of Patras | Greece

Dr. Eirini Kostopoulou is an Assistant Professor of Paediatric Endocrinology at the University of Patras School of Medicine, with advanced clinical and research training in Greece and leading academic hospitals in the United Kingdom. Her expertise spans paediatric obesity, monogenic and syndromic obesity, type one diabetes mellitus, growth and thyroid disorders, congenital hyperinsulinism, and lipid abnormalities. Her research focuses on molecular and genetic mechanisms underlying metabolic and endocrine diseases, including growth hormone signaling, oxidative stress, apoptotic pathways, and rare genetic causes of obesity, with direct translational impact on diagnosis and targeted therapies. She has authored a substantial body of peer-reviewed publications with strong citation impact and has contributed extensively through invited lectures, international collaborations, and multicenter clinical studies. Her work has advanced precision medicine approaches in paediatric endocrinology, improved early diagnosis of rare disorders, and strengthened clinical management strategies with meaningful societal and public health relevance. She has 499 citations from 77 documents with an h-index of 12.

Citation Metrics (Scopus)

800
600
400
200
0

Citations
499

Documents
77

h-index
12

🟦 Citations    🟥 Documents    🟩 h-index

View Google Scholar Profile
 View Scopus Profile

Featured Publications

Serhat Gürbüz | Clinical Medicine | Best Researcher Award

Published on by Health Scientists

Dr. Serhat Gürbüz | Clinical Medicine | Best Researcher Award 

Doctor of Medicine | University of Health Sciences | Turkey

Dr. Serhat Gürbüz, MD, MSc, is a distinguished Consultant in Orthopedics and Traumatology at the Metin Sabancı Baltalimanı Bone Diseases Training and Research Hospital, University of Health Sciences, Istanbul, Turkey. His professional expertise centers on knee, shoulder, and sports surgery, integrating advanced arthroscopic techniques and evidence-based rehabilitation strategies to restore function and improve patient outcomes. Dr. Gürbüz has contributed substantially to the field through scholarly publications in reputable peer-reviewed and indexed journals, clinical presentations, and collaborative research projects focused on musculoskeletal disorders and joint preservation. His work demonstrates a commitment to combining clinical excellence with translational research, contributing to the evolution of orthopedic surgical standards and innovations in minimally invasive procedures. He has maintained active collaborations with national and international orthopedic research groups and serves as a peer reviewer and academic contributor within the global orthopedic community. Dr. Gürbüz’s clinical practice reflects a deep dedication to advancing patient-centered care, surgical innovation, and academic mentorship, fostering the development of future orthopedic specialists. His academic engagement and research productivity underscore his contribution to scientific knowledge dissemination and the enhancement of evidence-based orthopedic medicine. Through his multidisciplinary collaborations and continuous pursuit of clinical innovation, Dr. Gürbüz has strengthened the bridge between medical research and practical application, ultimately promoting better musculoskeletal health and improving the quality of life for patients across diverse populations. He has 6 citations from 9 documents with an h-index of 2.

Profiles: Google Scholar | Scopus | ORCID

Featured Publications

1. Çelikoyar, M. M., Topsakal, O., & Gürbüz, S. (2019). Mobile technology for recording surgical procedures. Journal of Visual Communication in Medicine.

2. Imren, Y., Karslioglu, B., Dedeoglu, S. S., Cabuk, H., Atar, S., Gürbüz, S., … (2021). The effect of gluteus maximus tenotomy in primary total hip arthroplasty with posterior approach: Kinematic analysis of hip extensor strength. Journal of Orthopaedic Surgery.

3. Yüce, A., Yerli, M., Erkurt, N., Gürbüz, S., Çakar, M., & Adaş, M. (2022). Neutrophil-lymphocyte and C-reactive protein–albumin ratios as predictors of re-surgery in adult native knee septic arthritis. Journal of Clinical and Investigative Surgery.

4. Gürbüz, S., Bahar, H., Yavuz, U., Keskin, A., Karslioglu, B., & Solak, Y. (2025). Comparative efficacy of ChatGPT and DeepSeek in addressing patient queries on gonarthrosis and total knee arthroplasty. Arthroplasty Today.

5. Gürbüz, S., Ocak, O., Kir, M. C., Karslioglu, B., & Aki, S. (2025). Hyperchloremia at hospital admission for hip fractures is related with an increase in morbidity and mortality rates. Turkish Journal of Trauma and Emergency Surgery.

Dr. Serhat Gürbüz’s work advances global orthopedic science through innovative surgical techniques, evidence-based clinical research, and multidisciplinary collaborations that enhance musculoskeletal health. His commitment to patient-centered innovation and translational research contributes significantly to improving mobility, recovery, and quality of life in society worldwide.